Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

por Albinger, Nawid, Pfeifer, Rita, Nitsche, Marcus, Mertlitz, Sarah, Campe, Julia, Stein, Katja, Kreyenberg, Hermann, Schubert, Ralf, Quadflieg, Melissa, Schneider, Dina, Kühn, Michael W. M., Penack, Olaf, Zhang, Congcong, Möker, Nina, Ullrich, Evelyn
Publicado 2022

CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity

por Hejazi, Maryam, Zhang, Congcong, Bennstein, Sabrina B., Balz, Vera, Reusing, Sarah B., Quadflieg, Melissa, Hoerster, Keven, Heinrichs, Stefan, Hanenberg, Helmut, Oberbeck, Sebastian, Nitsche, Marcus, Cramer, Sophie, Pfeifer, Rita, Oberoi, Pranav, Rühl, Heiko, Oldenburg, Johannes, Brossart, Peter, Horn, Peter A., Babor, Florian, Wels, Winfried S., Fischer, Johannes C., Möker, Nina, Uhrberg, Markus
Publicado 2022